참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Methylhydrazine | HCID 6061 | — |
| 반응물 | N-Phthaloylglycine | HCID 20825 | — |
| 반응물 | N'-Hydroxycyclopropanecarboximidamide | HCID 2794666 | — |
| 반응물 | 4-(Aminomethyl)-3-cyclopropyl-1,2,4-oxadiazole | HCID 22713490 | — |
| 반응물 | N-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]phthalimide | HCID 22713498 | — |
| 용매 | 1,2-Dichloroethane | HCID 11 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| 생성물 | 3-cyclopropyl-[1,2,4]oxadiazol-5-ylmethyl-N,N-dimethyl-formamidine | HCID 86585599 | — |
반응 단계
Scheme 3 describes the preparation of known starting materials. The processes for preparation of these compounds are also known or may be carried out in analogous manner to known methods. For example, N-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]phthalimide is prepared by reaction of N-phthaloylglycine in DMF and 1,1′carbonyldiimidazole, and followed by the addition of cyclopropanecarboxamidoxime. The obtained N-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]phthalimide is then dissolved in 1,2-dichloroethane and N-methylhydrazine is added. The obtained 4-(aminomethyl)-3-cyclopropyl-1,2,4-oxadiazole is then treated with N,N-dimethylformaldehyde diethyl acetal and heated at about 130° C. and the desired starting material (E/Z)-N′-(3-cyclopropyl-[1,2,4]oxadiazol-5-ylmethyl-N,N-dimethyl-formamidine is obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06743789B2 |
|---|
| 출처 데이터셋 | uspto-grants-2004_06 |
|---|
| ORD ID | ord-72e9f2e9c5ca4a129d217bbf2e0400c1 |
|---|
| 출처 메모 | uspto-grants-2004_06 |
|---|